Aileen Fernandes

Aileen joined Arcellx in 2021 and currently serves as the Chief Business Officer. Prior to joining Arcellx, Aileen held many roles with increasing responsibility at Nevro Corporation including Chief of staff to the Chief Executive officer, Associate Director, Business Development and Strategy, and as a Director of Marketing where she was instrumental in leading the go-to-market commercial strategy for a new clinical indication. Prior to Nevro, Aileen was a management consultant at Deloitte Consulting., partnering with a wide range of companies across the healthcare sector, and held business development and marketing roles at multiple digital health startups. Aileen started her career at Morgan Stanley where she was a Finance Analyst. Aileen received an MBA from the Wharton School of the University of Pennsylvania and holds a BA in Economics from the Wharton School of the University of Pennsylvania.